Analyst Articles
6 Psychedelic-Treatment Clinic Stocks: An Overview
The size of the market for treatable mental health disorders is currently $300 billion in the U.S. and is expected to grow over the next five years. An opportunity exists for clinical-stage companies to commercialize their operations with alternative treatment methods to fill this need. The following article describes the commercialization developments, market capitalizations, and price performances of 6 companies in the industry. [more]